A. Antifibrinolytics B. Transfusing FFP C. Transfusing cryoprecipitate D. Hemodialysis

Similar documents
SARASOTA MEMORIAL HOSPITAL BLOOD COMPONENT CRITERIA AND INDICATIONS SCREENING GUIDELINES

INDICATIONS FOR BLOOD PRODUCT TRANSFUSIONS

Bleeding disorders or haemorrhagic diatheses are a group of disorders characterised by defective haemostasis with abnormal bleeding.

Subject: Severe Sepsis/Septic Shock Published Date: August 9, 2013 Scope: Hospital Wide Original Creation Date: August 9, 2013

Session Number 405 CERTIFICATION REVIEW: HEMATOLOGY AND IMMUNOLOGY

Introduction to Physical Evaluation. Part 2

Guideline Statement for the Treatment of Disseminated Intravascular Coagulation

DVT/PE Management with Rivaroxaban (Xarelto)

Why is prematurity a concern?

Note: Page numbers in italics indicate figures. Page numbers followed by a t indicate tables.

Sepsis Reassess patient Monitor and maintain respiratory/ hemodynamic status

Planning: Patient Goals and Expected Outcomes The patient will: Remain free of unusual bleeding Maintain effective tissue perfusion Implementation

BLOOD GROUP ANTIGENS AND ANTIBODIES

Physical Evaluation Part 2.0

Provided by the American Venous Forum: veinforum.org

To assist clinicians in the management of minor, major, and/or life-threatening bleeding in patients receiving new oral anticoagulants (NOACs).

- Lessons from SHOT Haemorrhage cases

Hummi Micro Draw Blood Transfer Device. The Next Generation System for Closed Micro Blood Sampling in the Neonate

Dr.U.Venkataramana Rao DNB Resident, Neonatology Unit, Southern Railway HQ Hospital.

Easy Bruising and Bleeding in the Adult Patient: A Sign of Underlying Disease

INTRODUCTION Thrombophilia deep vein thrombosis DVT pulmonary embolism PE inherited thrombophilia

Heparin Induced Thrombocytopenia

INTRODUCTION Thrombophilia deep vein thrombosis DVT pulmonary embolism PE inherited thrombophilia

Core Measures SEPSIS UPDATES


New Oral Anticoagulants

CONTEMPORARY REVERSAL OF ANTICOAGULATION

Yvette Marie Miller, M.D. Executive Medical Officer American Red Cross October 20, th Annual Great Lakes Cancer Nursing Conference Troy, MI

LABORATORY DIAGNOSIS OF BLEEDING DISORDERS

MANAGING BLEEDING IN THE

Interpretation of Laboratory Values

Streptococcal Infections

Coagulation Disorders In Pregnancy

Children ARE just small adults V I C K I L. S A K A T A, M D

Reversal of Antiplatelet and Anticoagulant Therapy: What You Need To Know. Ronald Walsh, MD Chief Medical Officer Community Blood Services

2002 burns responsible for 322,000 deaths world wide. aboriginal community in NA Most burns occur in the urban environment

Dengue haemorrhagic fever CHAPTER 3. Treatment

Blood Transfusion. Red Blood Cells White Blood Cells Platelets

Abnormal Basic Coagulation Testing Laboratory Testing Algorithms

Directed to Dr. Carrier from NBRHC audience Q: In patients with GI Bleed history, would you suggest Apixaban for newly diagnosed patients

Blood Transfusion. There are three types of blood cells: Red blood cells. White blood cells. Platelets.

MCHENRY WESTERN LAKE COUNTY EMS SYSTEM OPTIONAL CE ADVANCED LEVEL (EMTP, PHRN, ECRN) August Anticoagulants

Session 3 Topics. Argatroban. Argatroban. Drug Use and Adverse Effects. Laboratory Monitoring of Anticoagulant Therapy

Lynda Richardson, RN, BSN Sepsis/Septic Shock Abstractor. No disclosures

Delayed Cord Clamping

Overall Goals/Objectives - Surgical Critical Care Residency Program The goal of the Pediatric Surgical Critical Care Residency program is to provide

Dabigatran (Pradaxa) Guidelines

Hematology/Immunology/ Oncology

Coagulation Disorders in the ICU

Overview of Inflammation and Coagulation Brenda Lynn Morgan RN BScN MSc CNCC(C)

Investigation and treatment of liver disease with acute onset Local hospital protocol

Basic ATLS. The Primary Survey. Jason Smith MD DMI FRCS(Gen.Surg) Consultant Surgeon

Bakersfield College Associate Degree Nursing NURS B28 - Medical Surgical Nursing 4

Point-of-care testing Thrombelastography and platelet transfusion

Heparin-induzierte Thrombozytopenie Wann daran denken? Wie behandlen?

Hemostasis Problems in Critical Illness Per Thorborg, MD, PhD, FCCM

Hypertension in Pregnancy: Breaking down the new ACOG guidelines. Disclosures. Goals 4/21/2014. Michael Plevyak, MD 4/23/14. None

Speaker Disclosure. Outline. Pharmacist Objectives. Patient Case. Outline 9/4/2014

ELSO GUIDELINES FOR TRAINING AND CONTINUING EDUCATION OF ECMO SPECIALISTS

Sepsis: Identification and Treatment

Umbilical Cord Blood as Alternative for Infant Blood In Neonatal Sepsis Evaluation

Xabans Good for What Ails Ya? Brian Tiffany, MD, PhD, FACEP Dept of Emergency Medicine Chandler Regional Medical Center Mercy Gilbert Medical Center

QUICK REFERENCE. Mary Cushman 1 Wendy Lim 2 Neil A Zakai 1. University of Vermont 2. McMaster University

Obstetrics and Maternity

Thrombophilia. Steven R. Lentz, M.D. Ph.D. Carver College of Medicine The University of Iowa May 2003

Suffolk County Community College School of Nursing NUR 133 ADULT NURSING I

Level III Stroke Center Data Collection Requirements

CPT Pediatric Coding Updates The 2009 Current Procedural Terminology (CPT) codes are effective as of January 1, 2009.

Stop the Bleeding: Management of Drug-induced Coagulopathy. Stacy A. Voils, PharmD, BCPS Critical Care Specialist, Neurosurgery

Platelet Review July Thomas S. Kickler M.D. Johns Hopkins University School of Medicine

The Golden Rule of Specimen Collection: The Patient Test Result is Only as Good as the Sample We Get

Cirrhosis and Coagulation A Paradigm of Awareness Robert G. Gish MD

Traditional anticoagulants

EMMC Guide on Management of Anticoagulant and Anti-Platelet Agent Associated Bleeding Complications in Adults. February, 2013

Transfusion Medicine

Guidelines for diagnosis and management of acute pulmonary embolism

New Anticoagulants: What to Use What to Avoid

No Relevant Financial Disclosures

Critical Bleeding Reversal Protocol

The Rh Factor: How It Can Affect Your Pregnancy

Prevention and Recognition of Obstetric Fistula Training Package. Module 8: Pre-repair Care and Referral for Women with Obstetric Fistula

Title of Guideline. Thrombosis Pharmacist)

Hemostatic Defects in End Stage Liver Disease

PEDIATRIC TRANSFUSION GUIDELINES (Approved by Medical Staff Executive Committee on 12/11/2006) I. Red Blood Cells a

Damage Control in Abdominal Trauma

Blood products and pharmaceutical emergencies

Anticoagulation Essentials! Parenteral and Oral!

FAQs about Warfarin (brand name Coumadin )

Acute Myeloid Leukemia

GUIDE FOR HEART FAILURE TRANSFUSION MEDICINE SUPPORT (Coagulation-based Hemotherapy) Rev 12/16/2014 University of Texas-Medical School in Houston I.

Dr Anne Weaver London s Air Ambulance CODE RED THE BLEEDING PATIENT

New Anticoagulants: When and Why Should I Use Them? Disclosures

Clinical Reasoning Case Study: I. Data Collection Chief complaint/history of Present Illness:

NHS FORTH VALLEY RIVAROXABAN AS TREATMENT FOR DEEP VEIN THROMBOSIS AND PULMONARY EMBOLISM IN ADULTS

Hemostas under graviditet och förlossning. Ove Karlsson Sahlgrenska Universitetssjukhuset

Outpatient Treatment of Deep Vein Thrombosis with Low Molecular Weight Heparin (LMWH) Clinical Practice Guideline August 2013

HEMS in an urbansetting. Anne Weaver RESUS 2013, Limerick 27 th April 2013

PLATELETS: OVERVIEW. J. Kelton, M.D. May 3 rd, 2003

Medical Direction and Practices Board WHITE PAPER

How To Know If You Have A Bleeding Disorder

Transcription:

A TEN YEAR OLD BOY WITH NO SIGNIFICANT PMH PRESENTS TO THE EMERGENCY DEPARTMENT WITH A FEVER OF 103, RR IN THE 40S, HR OF 110, AND A BP OF 80/50. HE S ILL APPEARING AND PALE, WITH DELAYED CAPILLARY REFILL OF >3 SECONDS AND 1+ PULSES. TWO LARGE BORE IVS ARE PLACED AND FLUID RESUSCITATION IS STARTED, LAB AND CULTURES ARE DRAWN, ANTIBIOTICS STARTED. A FEW MINUTES AFTERWARD THE NURSE CALLS YOUR ATTENTION TO PERSISTENT OOZING OF BLOOD FROM BOTH C ATHETER SITES. YOU NOTICE NEW SCATTERED PETECHIAE ON THE PATIENT S SKIN. THE LAB CALLS WITH CRITICAL VALUES FOR SOME OF THE LABS YOU ORDERED: PT 18 PTT 121 INR 1.7 D DIMER 3 FIBRINOGEN 120 PLATELETS 75,000. YOU KNOW THE PATIENT IS MANIFESTING DISSEMINATED INTRAVASCULAR COAGULATION. THE NEXT BEST STEP IN TREATING THIS PATIENT S DIC IS: A. Antifibrinolytics B. Transfusing FFP C. Transfusing cryoprecipitate D. Hemodialysis

A TEN YEAR OLD BOY WITH NO SIGNIFICANT PMH PRESENTS TO THE EMERGENCY DEPARTMENT WITH A FEVER OF 103, RR IN THE 40S, HR OF 110, AND A BP OF 80/50. HE S ILL APPEARING AND PALE, WITH DELAYED CAPILLARY REFILL OF >3 SECONDS AND 1+ PULSES. TWO LARGE BORE IVS ARE PLACED AND FLUID RESUSCITATION IS STARTED, LAB AND CULTURES ARE DRAWN, ANTIBIOTICS STARTED. A FEW MINUTES AFTERWARD THE NURSE CALLS YOUR ATTENTION TO PERSISTENT OOZING OF BLOOD FROM BOTH C ATHETER SITES. YOU NOTICE NEW SCATTERED PETECHIAE ON THE PATIENT S SKIN. THE LAB CALLS WITH CRITICAL VALUES FOR SOME OF THE LABS YOU ORDERED: PT 18 PTT 121 INR 1.7 D DIMER 3 FIBRINOGEN 120 PLATELETS 75,000. YOU KNOW THE PATIENT IS MANIFESTING DISSEMINATED INTRAVASCULAR COAGULATION. THE NEXT BEST STEP IN TREATING THIS PATIENT S DIC IS: A. Antifibrinolytics B. Transfusing FFP C. Transfusing cryoprecipitate D. Hemodialysis

DIC: BLEEDING AND CLOTTING

COMMON CAUSES OF DIC IN KIDS Sepsis Trauma (ie severe brain injuries) Malignancies (ie AML) Newborns especially preterm - are vulnerable to DIC because the anticoagulants (antithrombin and protein C) are normally low at this age sepsis birth asphyxia respiratory distress syndrome (RDS) necrotizing enterocolitis (NEC)

COMMON THINGS THAT LOOK LIKE DIC IN KIDS Liver failure HELLP syndrome pregnant teens with HTN Massive transfusion replacement of more than 1 blood volume in 24 hours or the replacement of 50% of the total blood volume within 3 hours. TTP fever, thrombocytopenia, microangiopathic hemolytic anemia, renal failure, and neurologic signs. Screening coagulation tests (PT,PTT) are usually normal HUS microangiopathic hemolytic anemia, thrombocytopenia, and renal insufficiency in a kid <3 years

TREATMENT: 1. Treat underlying cause 2. Supportive care: transfuse for: 1. platelet counts <50,000/microL 2. fibrinogen concentration <100 mg/dl 3. prolonged APTT or PT (greater than 1.5 times the normal value)

TAKE HOME POINTS 1. Number one treatment for DIC is to aggressively treat the underlying cause 2. Key labs to get: Coags, Platelets, Ddimer, Fibrinogen 3. Multiple Scoring Systems to dx References: https://www.ncbi.nlm.nih.gov/pmc/articles/pmc4267589/ https://pediatriccare.solutions.aap.org/chapter.aspx?sectionid=137957861&bookid=1626#160127442 https://www.uptodate.com/contents/disseminated-intravascular-coagulation-in-infants-and-children?source=history_widget#h2